Offer - Urjas Oil for just ₹ 1 X
StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet safe for pregnant women?
StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet is safe to take during pregnancy.
Is the use of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet safe during breastfeeding?
Breastfeeding women can safely use StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet.
What is the effect of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet on the Kidneys?
StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet rarely harms the kidneys.
What is the effect of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet on the Liver?
The liver can be affected by StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet only after medical advice.
What is the effect of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet on the Heart?
No research work has been carried out till date on effects of StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet on heart. So it is not known whether taking StayHappi Doxylamine + Vitamin B6 + Folic Acid Tablet will cause side effects on heart or not.
StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet unless your doctor advises you to do so -
Is this StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet habit forming or addictive?
Forming a habit of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet has not been reported.
Interaction between Food and StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet
Taking StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet
It is difficult to say anything about the effect of StayHappi Doxylamine Succinate 10 Mg + Folic Acid 2.5 Mg + Pyridoxine HCl 10 Mg Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 469
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 663
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bonjesta (doxylamine succinate and pyridoxine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclegis (doxylamine succinate and pyridoxine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611